Concepedia
3
Publications
68
Citations
H-Index
2022
Active since
Affiliations
Manchester University NHS Foundation Trust(Current)
Peter MacCallum Cancer Centre
University College London
Beatson West of Scotland Cancer Centre
University College Hospital
Michael Northend is an author at Manchester University NHS Foundation Trust.
Publications per year
2022–2024
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
Michael Northend, William Wilson, Wendy Osborne et al. · Blood Advances · 2022 · 41 citations · Full text
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Michael S. Binkley, Jamie E. Flerlage, Kerry J. Savage et al. · Journal of Clinical Oncology · 2024 · 14 citations
Long Term Follow-up of International Randomised Phase 3 Study of Rituximab Versus a Watch and Wait Approach for Patients with Asymptomatic, Low Tumour Burden Follicular Lymphoma Shows Rituximab Is Highly Effective at Delaying Time to New Treatment without Detrimental Impact Following Next Line of Therapy
Michael Northend, William Wilson, Laura Clifton‐Hadley et al. · Blood · 2022 · 13 citations
Rows per page
1–3 of 3